•  
  •  
 

Abstract

Background: Adverse drug reactions (ADRs) are a critical component of patient safety; however, ADR monitoring remains underutilized in dentistry. This study aimed to assess knowledge, attitudes, and practices regarding ADR reporting among undergraduate and postgraduate students and practicing dentists.

Methods: A cross-sectional observational study was conducted using a structured, validated 19-item questionnaire covering socio-demographics, knowledge (6 items), attitude (4 items), and practice (5 items), which was distributed both in person and online. A total of 258 complete responses were analyzed out of 300 individuals contacted (response rate: 86%). Descriptive statistics and Chi-square tests were applied, with p < 0.05 considered statistically significant.

Results: Among participants, 29% were male, and 71% were female; 29.4% were undergraduates, and 71.6% were postgraduates/practitioners. While 98% recognized the importance of ADR reporting, only 7.3% had received formal training in pharmacovigilance, and 71.7% were unaware of reporting procedures. Nearly 46.5% had encountered ADRs in clinical practice. Despite adequate knowledge and positive attitudes, actual reporting practices were limited.

Conclusions: Although awareness and attitudes toward ADR reporting were favorable, significant gaps exist in formal training and reporting practices. Integrating structured pharmacovigilance education into dental curricula may enhance ADR reporting and improve patient safety outcomes.

References

  1. Halling F, Lutz R, Meisgeier A. Trends in adverse drug reaction reporting by dentists: a 15-year analysis of German pharmacovigilance data. Clin Oral Investig. 2026;30:204.
  2. Ouanounou A, Ng K, Chaban P. Adverse drug reactions in dentistry. Int Dent J. 2020;70(2):79–84.
  3. Matar MS, Elatta LS, Basheir WA, Khalid KM, Babiker DH, Yousef BA. Pharmacovigilance in dental practice: Opportunities for pharmacy-dentistry collaboration. Ann Med Med Sci. 2025;04:1283–90.
  4. Bakhtiari S, Sehatpour M, Mortazavi H, Bakhshi M. Orofacial manifestations of adverse drug reactions: a review study. Clujul Med. 2018;91(1):27–36.
  5. Lu S-Y. Oral candidosis: Pathophysiology and best practice for diagnosis, classification, and successful management. J Fungi. 2021;7(7):555.
  6. Kengar MD, Patole KK, Ade AK, Kumbhar SM, Patil CD, Ganjave AR. Introduction to pharmacovigilance and monitoring. Asian J Pharm Res. 2019;9(2):116–22.
  7. Romero MR. Pharmacovigilance and toxicovigilance development in dentistry. J Pharm Pharmacol. 2017;5:697–702.
  8. Khan Z, Öz E, Kıroğlu O, Karataş Y. Analysis of adverse drug reactions in hospitalised patients reported to the pharmacovigilance centre in a teaching hospital. Cukurova Med J. 2020;45(2):556–61.
  9. Ochyra D, Ochyra B, Misztal Z, Pawlicka M, Pawlicki M, Mroczek A, et al. Importance of adverse drug reaction reporting in dental practice. J Edu Health Sport. 2018;8(9):1067–73.
  10. Chhabra C, Chhabra KG, Sharma A, Goyal A, Rajesh G, Binnal A. Pharmacovigilance: the least understood and least practiced science in dentistry. World J Dent. 2019;10(5):402–6.
  11. Fornasier G, Francescon S, Leone R, Baldo P. An historical overview of pharmacovigilance. Int J Clin Pharm. 2018;40(4):744–7.
  12. Sachdev R, Grag K, Singh G, Mehrotra V. Pharmacovigilance: An emerging trend in dental practice of India. RGUHS J Dent Sci. 2020;12(1):57–64.
  13. Jadhav A, Chandrikapure A, Tarte P. Pharmacovigilance in dental practice: A study to evaluate knowledge, attitude and practices (KAP) of reporting of adverse drug reactions (ADR) among dental practitioners in a city of the central region of Maharashtra, India. MedPulse-Int J Dent. 2017;2(2):14–8.
  14. Chhabra KG, Chhabra C, Reddy JJ, Deolia SG, Mittal Y. Knowledge, attitude, and practices regarding pharmacovigilance and adverse drug reaction reporting among dental students in a teaching hospital, Jodhpur, India: a cross-sectional study. J Contemp Dent Pract. 2016;18(10):964–9.
  15. Nisa ZU, Zafar A, Sher F. Assessment of knowledge, attitude and practice of adverse drug reaction reporting among healthcare professionals in secondary and tertiary hospitals in the capital of Pakistan. Saudi Pharm J. 2018;26:453–61.
  16. Karataş Y, Khan Z, Özagil ES, Abussuutoğlu AB, Pelit A, Koçak E. Knowledge, attitude and practices about pharmacovigilance and adverse drug reactions among dental research assistants in a Turkish hospital: a cross-sectional study. J Health Sci Med. 2020;3(4):367–71.
  17. Korde RA, Shodan P. Knowledge, attitude, and practice of pharmacovigilance among undergraduate medical and dental students in a tertiary care teaching hospital. Int J Med Pharm Res. 2026;7(1):990–5.
  18. Manandhar T. Knowledge, attitude and practice of pharmacovigilance among undergraduate medical and dental students of a tertiary care teaching hospital. J Chitwan Med Coll. 2022;12(42):12–6.
  19. Ncube N, Lubbe MS, Steyn H, Motaze NV. Awareness and attitudes regarding adverse drug events and reporting in South Africa. Ther Innov Regul Sci. 2025;59:882–91.
  20. PotlogShchory M, Goldstein LH, Arcavi L, Shihmanter R, Berkovitch M, Levy A. Increasing adverse drug reaction reporting—How can we do better? PLoS One. 2020;15(8):e0235591.
  21. Güner MD, Ekmekci PE. Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behaviour and factors determining the reporting rates. J Drug Assess. 2019;8(1):13–20.
  22. Bhattarai AK, Shrestha MV, Bhattarai B. Knowledge, attitude, and practice of pharmacovigilance among the dental doctors and interns of Nepal. J Nepal Dent Assoc. 2024;24(38):30–7.
  23. Gupta SK, Nayak RP, Shivaranjani R, Vidyarthi SK. A questionnaire study on the knowledge, attitude, and practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India. Perspect Clin Res. 2015;6(1):45–52.
  24. Haritha GN, Rama A, Naha A, Rani U. Evaluation of knowledge, attitude, and practice of medical and dental postgraduates toward reporting of adverse drug reactions in a teaching hospital, South India. J Appl Pharm Sci. 2022;12(09):025–33.
  25. Acharya R, Naik R, Rang S, Jani CA, R G, Rath S. The Knowledge, attitude, and practice among Ayurvedic scholars and trainees towards pharmacovigilance: a questionnaire-based survey in Gujarat, India. J Pharmacovigil Drug Res. 2022;3(1):26–38.
  26. Thakuria N, Deka D, Choudhury D, Ahmed N. A cross-sectional study to evaluate the knowledge, attitude and practices of healthcare professionals on pharmacovigilance at Silchar Medical College and Hospital, Assam, India. Int J Basic Clin Pharmacol. 2016;5(4):1481–9.
  27. Li R, Curtis K, Van C, Tabish Razi Zaidi S, Yeo CY, Arun Kali C, et al. Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework. Eur J Clin Pharmacol. 2022;78(7):1165–75.
  28. Seselja Perisin A, Bukic J, Rusic D, Leskur D, Bozic J, Mihanovic A, et al. Teaching pharmacovigilance to healthcare students: identifying gaps and opportunities for improvement. Pharmacy. 2021;9(3):147.
  29. Mannucci C, Dante G, Miroddi M, Facchinetti F, D’Anna R, Santamaria A, et al. Vigilance on use of drugs, herbal products, and food supplements during pregnancy: focus on fosfomycin. J Maternal-Foetal Neonatal Med. 2019;32(1):125–8.

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.